SCHEDULE 13D/A: 23andMe Founder Anne Wojcicki Proposes $0.41 Per Share Buyout to Take Company Private

23andMe Holding Co. founder Anne Wojcicki has submitted a non-binding proposal to acquire all outstanding shares not already owned by her and affiliates for $0.41 per share in cash, aiming to take the company private.

Summary

• Anne Wojcicki has submitted a non-binding proposal to acquire all outstanding shares of 23andMe Holding Co. not owned by her and her affiliates (or invited rollover stockholders) for cash consideration of $0.41 per share.
• The proposal includes a commitment from Ms. Wojcicki to provide $30 million of unsecured financing to the Company to fund operations through the closing of the potential transaction, at a 7% interest rate.
• The proposed transaction is not subject to any financing contingency, but is subject to customary conditions, including material governmental consents and the absence of any material adverse change.
• Ms. Wojcicki's proposal is contingent upon approval by the Special Committee of the Board of Directors, with the assistance of its own legal and financial advisors.
• The transaction also requires a non-waivable condition of approval by a majority of the shares of common stock not owned by Ms. Wojcicki, any other stockholders invited to roll over their shares, or their respective affiliates.
• Total sources of funds for the proposed transaction are $42 million, consisting of $2 million in Anne Wojcicki's rollover equity, $10 million in new capital, and a $30 million bridge loan.
• The uses of these funds are allocated as $12 million for the equity purchase price and $30 million for funding the Company's operations.
• New Mountain, a previously interested party in a potential acquisition, informed Ms. Wojcicki on February 28, 2025, that it was no longer interested and would discontinue discussions.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the proposal offers immediate liquidity and is not subject to financing contingency, the offer price is relatively low, and a previous potential partner (New Mountain) has withdrawn. The non-binding nature and material adverse change clause introduce uncertainty, balancing the positive aspects of the committed financing and governance safeguards.

Positives

• The proposal offers immediate liquidity to the Company's public stockholders.
• The transaction is not subject to any financing contingency, indicating a firm commitment from the proposer.
• Anne Wojcicki is willing to provide $30 million in unsecured financing to support the Company's operations through the closing period.
• The proposal includes strong corporate governance safeguards, requiring approval from the Special Committee and a majority of unaffiliated shareholders.

Negatives

• The offer price of $0.41 per share may be considered low by some investors.
• New Mountain, a potential partner in a previous acquisition proposal, has withdrawn from discussions.
• The proposal is non-binding and subject to negotiation and execution of definitive documentation, with no assurance of completion.
• The transaction is subject to a 'material adverse change' condition, which could allow the proposer to withdraw.

Risks

• There is no assurance that the non-binding proposal will result in any definitive agreement, transaction, or any other strategic alternative.
• The March 2 Proposal may be modified or withdrawn by the Reporting Persons at any time without prior notice.
• The closing of the transaction is subject to the satisfaction of customary conditions, including the receipt of all material governmental consents and approvals.
• The transaction is subject to the absence of any material adverse change in the business, assets, condition (financial or otherwise), results of operations, cash flows or properties of the Company and its subsidiaries, taken as a whole.

Future Outlook

Anne Wojcicki believes that taking 23andMe private is the best course of action, as it will enable the Company to focus on executing long-term value creation initiatives away from public market pressures.

Management Comments

• "I, Anne Wojcicki, am pleased to submit this proposal for the acquisition of all of the outstanding shares of capital stock of 23andMe Holding Co. ... not owned by me and my affiliates ... for cash consideration of $0.41 per share."
• "I believe that my Proposal provides compelling value and immediate liquidity to the Company's public stockholders."
• "I continue to believe the best course of action is for the Company to go private, which will enable it to focus on executing long-term value creation initiatives."
• "I believe that my Proposal provides significant value to the Company and its stockholders and that moving forward with my Proposal is in the best interests of the Company and its customers, employees, and unaffiliated stockholders."

Industry Context

The proposal to take 23andMe private aligns with a broader trend where founders or major shareholders seek to delist companies, particularly in sectors like biotechnology or direct-to-consumer genomics, to pursue long-term strategic goals without the immediate pressures of public market scrutiny and quarterly reporting. This strategy is often employed by companies requiring significant R&D investment or facing market challenges, allowing for greater operational flexibility.

Corporate Governance

Related Party Transactions

• The acquisition proposal itself is a related party transaction, as it is submitted by Anne Wojcicki, the founder and a significant beneficial owner of 23andMe Holding Co.
• The proposed $30 million unsecured financing to the Company from Anne Wojcicki is a related party transaction.

Stakeholder Impact

• **Shareholders**: Public shareholders would receive immediate cash liquidity at $0.41 per share. Unaffiliated shareholders have a specific approval right, providing a check on the transaction.
• **Employees**: Ms. Wojcicki states the proposal is in the best interests of employees, suggesting a focus on long-term stability and value creation post-privatization.
• **Customers**: Ms. Wojcicki also states the proposal is in the best interests of customers, implying continued service and focus on the Company's core offerings.
• **Creditors**: The provision of a $30 million unsecured bridge loan from Ms. Wojcicki could impact the Company's debt structure and financial health, potentially affecting existing creditors.

Next Steps

• Negotiation and execution of mutually agreeable definitive documentation for the Potential Transaction.
• Discussions between Anne Wojcicki and her advisors with the Special Committee regarding the terms of the March 2 Proposal.
• Obtaining all material governmental consents and approvals required for the transaction.
• Approval of the proposal by the Special Committee of the Board of Directors.
• Approval of the transaction by a majority of the shares of common stock not owned by Anne Wojcicki, rollover stockholders, or their affiliates.

Key Dates

Recommendation

Keywords

23andMe, Anne Wojcicki, acquisition proposal, going private, buyout, Schedule 13D, genetic testing, biotechnology, direct-to-consumer genomics, special committee, shareholder approval, corporate governance